Last reviewed · How we verify

Toragesic® — Competitive Intelligence Brief

Toragesic® (Toragesic®) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID. Area: Pain management.

phase 3 NSAID COX-2 Pain management Small molecule Live · refreshed every 30 min

Target snapshot

Toragesic® (Toragesic®) — Apsen Farmaceutica S.A.. Toragesic is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting prostaglandin synthesis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Toragesic® TARGET Toragesic® Apsen Farmaceutica S.A. phase 3 NSAID COX-2
Celebrex celecoxib Pfizer Inc. (originally Searle/Pharmacia) marketed Nonsteroidal Anti-inflammatory Drug [EPC] COX-2 1998-12-31
Cytotec Misoprostol Pfizer marketed NSAID combined with prostaglandin analog Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors 1988-01-01
Etoricoxib (Arcoxia) Etoricoxib (Arcoxia) Radboud University Medical Center marketed Selective COX-2 inhibitor (coxib) COX-2 (Cyclooxygenase-2)
ASA ASA Biogen marketed Nonsteroidal anti-inflammatory drug (NSAID); antiplatelet agent Cyclooxygenase-1 (COX-1); Cyclooxygenase-2 (COX-2)
Ropivacaine Ketorolac Ropivacaine Ketorolac University of Aarhus marketed Local anesthetic + NSAID combination Voltage-gated sodium channels (ropivacaine); COX-1/COX-2 (ketorolac)
hydrochloride hydromorphone + flurbiprofen axetil hydrochloride hydromorphone + flurbiprofen axetil First Affiliated Hospital, Sun Yat-Sen University marketed Opioid analgesic + NSAID combination Mu-opioid receptor (hydromorphone); COX-1/COX-2 (flurbiprofen axetil)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (NSAID class)

  1. Antibe Therapeutics Inc. · 3 drugs in this class
  2. Iroko Pharmaceuticals, LLC · 3 drugs in this class
  3. Organon and Co · 2 drugs in this class
  4. Apsen Farmaceutica S.A. · 2 drugs in this class
  5. Amneal Pharmaceuticals, LLC · 2 drugs in this class
  6. Behar, Caren, M.D. · 2 drugs in this class
  7. IDEA AG · 2 drugs in this class
  8. Noven Pharmaceuticals, Inc. · 2 drugs in this class
  9. HALEON · 2 drugs in this class
  10. Pfizer · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Toragesic® — Competitive Intelligence Brief. https://druglandscape.com/ci/toragesic. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: